Cardiac Sympathetic Dominance and Systemic Inflammation in COPD

References

• Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. MMWR Surveill Summ 2002; 51:1–16.
   PubMed Web of Science ®Google Scholar
• Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22:809–814.
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SFP. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2:8–11.
   PubMedGoogle Scholar
• Gross NJ. The influence of anticholinergic agents on treatment for bronchitis and emphysema. Am J Med 1991; 91:11S–12S.
   Google Scholar
• Undem BJ, Kollarik M. The role of vagal afferent nerves in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:355–360.
   PubMedGoogle Scholar
• Stewart AG, Waterhouse JC, Howard P. Cardiovascular autonomic nerve function in patients with hypoxemic chronic obstructive pulmonary disease. Eur Respir J 1991; 4:1207–1214.
   PubMed Web of Science ®Google Scholar
• Stewart AG, Marsh F, Waterhouse JC, Howard P. Autonomic nerve dysfunction in COPD as assessed by the acetylcholine sweat-spot test. Eur Respir J 1994; 7:1090–1095.
   PubMed Web of Science ®Google Scholar
• Chhabra SK, De S. Cardiovascular autonomic neuropathy in chronic obstructive pulmonary disease. Respir Med 2005; 99:126–133.
   PubMed Web of Science ®Google Scholar
• Heindl S, Lehnert M, Criée C, Hasenfuss G, Andreas S. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001; 164:597–601.
   PubMed Web of Science ®Google Scholar
• Volterrani M, Scalvini S, Mazzuero G, Lanfranchi P, Colombo R, Clark AL, Levi G. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 1994; 106:1432–1427.
   PubMed Web of Science ®Google Scholar
• Pagani M, Lucini D, Pizzinelli P, Sergi M, Bosisio E, Mela GS, Malliani A. Effects of aging and of chronic obstructive pulmonary disease on RR interval variability. J Auton Nerv Syst 1996; 59:125–132.
   PubMedGoogle Scholar
• Stein PK, Nelson P, Rottman JN, Howard D, Ward SM, Kleiger RE, Senior RM. Heart rate variability reflects severity of COPD in PiZ α1-antitrypsin deficiency. Chest 1998; 113:327–333.
   PubMed Web of Science ®Google Scholar
• Scalvini S, Porta R, Zanelli E, Volterrani M, Vitacca M, Pagani M, Giordano A, Ambrosino N. Effects of oxygen on autonomic nervous system dysfunction in patients with chronic obstructive pulmonary disease. Eur Respir J 1999; 13:119–124.
   PubMed Web of Science ®Google Scholar
• Tug T, Terzi SM, Yoldas TK. Relationship between the frequency of autonomic dysfunction and the severity of chronic obstructive pulmonary disease. Acta Neurol Scand 2005; 112:183–188.
   PubMed Web of Science ®Google Scholar
• Chen WL, Chen GY, Kuo CD. Hypoxemia and autonomic nervous dysfunction in patients with chronic obstructive pulmonary disease. Respir Med 2006; 100:1547–1553.
   PubMed Web of Science ®Google Scholar
• Raupach T, Bahr F, Herrmann P, Luethje L, Heusser K, Hasenfuss G, Bernardi L, Andreas S. Slow breathing reduces sympathoexcitation in COPD. Eur Respir J 2008; 32:387–392.
   PubMed Web of Science ®Google Scholar
• Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93:1043–1065.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Fei L. Chronotropic incompetence-part I. Normal regulation of the heart rate. Clin Cardiol 1996; 19:424–428.
   PubMed Web of Science ®Google Scholar
• Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59:256–262.
   PubMed Web of Science ®Google Scholar
• Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84:1482–1492.
   Google Scholar
• Malpas SC, Maling TJB. Heart rate variability and cardiac autonomic function in diabetes. Diabetes 1990; 39:1177–1181.
   PubMed Web of Science ®Google Scholar
• Schwartz PJ, La Rovere MT. ATRAMI: a mark in the quest for the prognostic value of autonomic markers. Eur Heart J 1998; 19:1593–1595.
   PubMed Web of Science ®Google Scholar
• Vita G, Bellinghieri G, Trusso A, Costantino G, Santoro D, Monteleone F, Messina C, Savica V. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int 1999; 56:232–237.
   PubMed Web of Science ®Google Scholar
• Andreas S, Anker SD, Scanlon PD, Somers VK. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest 2005; 128:3618–3624.
   PubMed Web of Science ®Google Scholar
• van Gestel AJR, Kohler M, Clarenbach CF. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease. Discov Med 2012; 14:359–368.
   PubMed Web of Science ®Google Scholar
• Jensen MT, Marott JL, Lange P, Vestbo J, Schnohr P, Nielsen OW, Jensen JS, Jensen GB. Resting heart rate is a predictor of mortality in COPD. Eur Respir J 2013; 42:341–349.
   PubMed Web of Science ®Google Scholar
• Jensen MT, Marott JL, Allin K, Nordestgaard BG, Jensen GB. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study. Eur J Prev Cardiol 2012; 19:102–108.
   PubMed Web of Science ®Google Scholar
• GOLD strategy for diagnosis, management and prevention of chronic obstructive pulmonary disease. Executive summary update 2009. www.goldcopd.org (accessed 29 October, 2013).
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
   PubMed Web of Science ®Google Scholar
• ATS committee on proficiency standards for clinical pulmonary function laboratories. ATS Statement: Guidelines for the six minute walk test. Am J Respir Crit Care Med 2002; 166:111–117.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnoea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005–1012.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:14–20.
   PubMed Web of Science ®Google Scholar
• van Gestel AJR, Steier J. Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD). J Thorac Dis 2010; 2:215–222.
   PubMedGoogle Scholar
• Nadeem A, Raj HG, Chhabra SK. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation 2005; 29:23–32.
   PubMed Web of Science ®Google Scholar
• Ye S, Zhong H, Yanamadala S, Campese VM. Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension 2006; 48:309–315.
   PubMed Web of Science ®Google Scholar
• Kishi T, Hirooka Y. Central mechanisms of abnormal sympathoexcitation in chronic heart failure. Cardiol Res Pract 2012; 2012:847172.
   PubMedGoogle Scholar
• Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004; 25:363–370.
   PubMed Web of Science ®Google Scholar
• Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watson KE. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010; 362:217–227.
   PubMed Web of Science ®Google Scholar
• Gupta M, Bansal V, Chhabra SK. Abnormal heart rate recovery and chronotropic incompetence on exercise in chronic obstructive pulmonary disease. Chron Respir Dis 2013; 10:117–126.
   PubMedGoogle Scholar
• Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. Br Med J 2011; 342:d2549.
   PubMed Web of Science ®Google Scholar
• van Gestel YR, Hoeks SE, Sin DD, Welten GM, Schouten O, Witteveen HJ, Simsek C, Stam H, Mertens FW, Bax JJ, van Domburg RT, Poldermans D. Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. Am J Respir Crit Care Med 2008; 178:695–700.
   PubMed Web of Science ®Google Scholar